Updated COVID boosters targeting Omicron start rolling out
Federal health officials say thousands of updated booster shots are already being shipped around the country.
Watch CBS News
Federal health officials say thousands of updated booster shots are already being shipped around the country.
The FDA's panel of vaccine advisers voted unanimously that the benefits of Pfizer's and Moderna's shots outweigh the risks in young children.
The company says it'll give U.S. regulators the data soon. Moderna is already seeking U.S. clearance to vaccinate kids 5 and under.
Studies found that the effectiveness of two doses of Pfizer's vaccine for children ages 5 to 12 dropped substantially during the Omicron surge.
This is the first antiviral Covid-19 pill authorized for ill people to take at home, before they get sick enough to be hospitalized.
Pfizer announced new results on Tuesday from studies testing its five-day course of COVID antiviral pills, confirming Paxlovid cut the risk of hospitalization or death in a trial for patients at high-risk of severe COVID-19 by 89% when treated within the first three days of their symptoms.
The Food and Drug Administration has greenlighted a request from Pfizer and BioNTech to allow Americans as young as 16 to get a booster shot of their COVID-19 vaccine.
Pfizer announced Friday that its experimental antiviral pill for COVID-19 cuts rates of hospitalization and death by nearly 90%.
Orange County's children aged 5 to 11 years old will be able to get vaccinated against COVID-19, officials said Wednesday.
A panel of the Centers for Disease Control and Prevention's outside vaccine advisers voted unanimously Tuesday to recommend Pfizer's COVID-19 vaccine for children as young as 5.
If the agency decides to allow the vaccine, the Biden administration says up to 15 million child-sized doses of Pfizer's vaccine could be shipped out to providers immediately after the FDA's decision.
Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 -- and if regulators agree, shots could begin within a matter of weeks.
Booster-eligible adults include those over the age of 65 and people 18-64 who are are at high risk for severe illness.
Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon -- a key step toward beginning vaccinations for youngsters.
A panel of the FDA's vaccine advisers voted to unanimously endorse Pfizer booster shots for elderly and high-risk Americans.
The coronavirus vaccine from pharmaceutical giant Pfizer has received full approval from the Food and Drug Administration.
Full approval by the U.S. Food and Drug Administration of the Pfizer/BioTech coronavirus vaccine is expected soon, according to reports.
Orange County's COVID-19 hospitalizations remained stable again Friday, prompting one epidemiologist to speculate the county may have reached its peak in this latest Delta variant-fueled surge.
This is the first Covid-19 vaccine in the United States authorized for use in younger teens and adolescents; the vaccine had previously been authorized for people age 16 and older.
The Food and Drug Administration is expected to authorize Pfizer-BioNTech's COVID-19 vaccine for administration to adolescents by early next week, according to a federal health official with knowledge of the agency's plans.
Drug-maker Pfizer made a big announcement Wednesday that its COVID-19 vaccine is 100 percent protective in kids as young as 12 years old.
A 60-year-old Orange County man died after receiving a second dose of the coronavirus vaccine. Now investigators are trying to determine if the vaccination played any role in his death.
Under the $2 billion deal announced Wednesday, the companies will deliver at least 70 million of the additional doses by June 30, with the remaining 30 million doses to be delivered no later than July 31.
The first batch of the Pfizer vaccine arrived at LAX Sunday evening.
The Food and Drug Administration on Friday authorized Pfizer's coronavirus vaccine for emergency use, kicking off a massive effort to initially deliver nearly 3 million doses of the vaccine to more than 600 sites nationwide.
